Results 61 to 70 of about 858,476 (293)

Access to anticancer medicines in public hospitals of Northwestern China

Frontiers in Public Health, 2023
ObjectiveWe aimed to evaluate the accessibility of anticancer medicines in public hospitals of Shaanxi, a representative province of Northwestern China.MethodsThirty-one anticancer medicines were investigated in 146 designated public hospitals in 10 ...
Yue Ma, Yue Ma, Yue Ma, Yue Ma, Jin Peng, Jin Peng, Jin Peng, Jin Peng, Xuelin Yao, Xuelin Yao, Xuelin Yao, Xuelin Yao, Liuxin Feng, Xinke Shi, Minghuan Jiang, Minghuan Jiang, Minghuan Jiang, Minghuan Jiang   +17 more
doaj   +1 more source

Defining daily doses and total doses for the measurement of antibiotic usage in Swiss pig production [PDF]

Schweiz Arch Tierheilkd, 2018
A significant Antibiotic-Monitoring-System is essential to analyse the use of antibiotics and to a better understanding of trends in resistance development. In human and veterinary medicine, for example, a system based on defined daily and treatment doses (Defined Daily Dose: DDD and Defined Course Dose: DCD) is applied.
T, Echtermann, C R, Müntener, P R, Torgerson, X, Sidler, D, Kümmerlen   +4 more
openaire   +2 more sources

Antimicrobial use in pigs, broilers and veal calves in Belgium [PDF]

, 2014
Given the risks associated with antimicrobial resistance and its link with antimicrobial use, available data on antimicrobial use in the Belgian pig, broiler and veal calf production were compared. Allowing for comparison of the data available from three
Callens, Benedicte, Dewulf, Jeroen, Filippitzi, Maria-Eleni, Pardon, Bart, Persoons, Davy   +4 more
core  

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. [PDF]

, 2015
BackgroundBudesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis.AimThe aim of ...
Barrett, Andrew C, Bortey, Enoch, Bosworth, Brian, Forbes, William P, Golden, Pamela L, Gordon, Glenn L, Rolleri, Robert L, Rubin, David T, Sale, Mark E, Sandborn, William J, Zakko, Salam   +10 more
core   +3 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load

International Journal of Clinical Pharmacy, 2019
Background Antipsychotic polypharmacy ("polypharmacy") is the concurrent prescribing of more than one antipsychotic. It is widely practised, as reported in the literature, and is known to increase the risk of adverse outcomes for patients. Objective To quantify the prevalence and magnitude of polypharmacy in patients with schizophrenia or ...
My Linh Nguyen, Bruce Sunderland, Stephen Lim, Laetitia Hattingh, Leanne Chalmers   +4 more
openaire   +3 more sources

Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment [PDF]

Pharmacoepidemiology and Drug Safety, 2017
AbstractObjectiveTo assess how well the defined daily dose (DDD) metric reflects opioid utilisation among chronic non‐cancer pain patients.DesignDescriptive, cross‐sectional study, utilising a 7‐day medication diary.SettingCommunity‐based treatment settings, Australia.SubjectsA sample of 1101 people prescribed opioids for chronic non‐cancer pain ...
Nielsen, S, Gisev, N, Bruno, R, Hall, W, Cohen, M, Larance, B, Campbell, G, Shanahan, M, Blyth, F, Lintzeris, N, Pearson, S, Mattick, R, Degenhardt, L   +12 more
openaire   +3 more sources

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome [PDF]

, 2019
© The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the ...
Gorog, Diana A, Gue, Ying X, Kanji, Rahim, Srinivasan, Manivannan, Wellsted, David M, Wyatt, Solange   +5 more
core   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source